펜실베이니아의 크론병 임상 시험
크론병 관련 연구 23개가 펜실베이니아 내 여러 지역에서 참여자를 모집하고 있습니다.
펜실베이니아의 도시
공식 연구 텍스트(영어)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Penn State University Milton S. Hershey Medical Center ( Site 5102), Hershey
- Thomas Jefferson University Hospital ( Site 5133), Philadelphia
- Frontier Clinical Research, LLC ( Site 5098), Uniontown
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT06430801A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Susquehanna Research Group, Harrisburg
- Penn State Milton S Hershey Medical Ctr, Hershey
- University of Pennsylvania, Philadelphia
- 외 1개
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07196722A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Frontier Clinical Research, Uniontown
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07499232A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Children's Hospital of Philadelphia, Philadelphia
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 265904, Philadelphia
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06548542Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06937099An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Penn State Milton S. Hershey Medical Center-Site Number: 8400066, Hershey
- University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
- The Allegheny Health Network (AHN) Center for Digestive Health-Site Number: 8400107, Pittsburgh
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
- The Allegheny Health Network (AHN) Center for Digestive Health-Site Number: 8400107, Pittsburgh
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07184944Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT03816345A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Children's Hospital of Philadelphia (CHOP), Philadelphia
피험자 모집 중3상
2세 ~ 19세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT04844606A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Allegheny Health Network, Wexford
피험자 모집 중4상
18세 ~ 70세 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06045754A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Children's Hospital of Philadelphia, Philadelphia
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT05509777Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
- Children's Hospital of Philadelphia - Main /ID# 262197, Philadelphia
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 6. 24. 업데이트됨 · NCT06332534A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Penn State Health Milton South Hershey Medical Center, Hershey
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 6. 22. 업데이트됨 · NCT06405087Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Children's Hospital of Philadelphia, Philadelphia
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
피험자 모집 중4상
6세 ~ 17세 · 모든 성별 · 2026. 5. 27. 업데이트됨 · NCT05781152A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Children's Hospital of Pittsburgh, Pittsburgh
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT04779320Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Susquehanna Research Group, LLC, Harrisburg
- UPMC, Pittsburgh
- Frontier Clinical Research, LLC, Uniontown
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 4. 27. 업데이트됨 · NCT06456593COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
- University of Pittsburgh Medical Center, Children's Hospital, Pittsburgh
피험자 모집 중관찰 연구
1세 ~ 18세 · 모든 성별 · 2026. 4. 17. 업데이트됨 · NCT07198113A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400009, Harrisburg
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 3. 27. 업데이트됨 · NCT06958536Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
피험자 모집 중관찰 연구
2 Months – 60 Years · 모든 성별 · 2026. 1. 13. 업데이트됨 · NCT04528355Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
피험자 모집 중2상
2 Months – 55 Years · 모든 성별 · 2025. 12. 15. 업데이트됨 · NCT01962415Autologous Stem Cell Transplantation for Crohn's Disease
- UPMC Prebyterian- Adult Gastroenterology, Pittsburgh
- Children's Hospital of Pittsburgh of UPMC-Bone Marrow Team, Pittsburgh
피험자 모집 중1/2상
10세 ~ 60세 · 모든 성별 · 2025. 12. 15. 업데이트됨 · NCT00692939Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
- Children's Hospital of Philadelphia, Philadelphia
피험자 모집 중
8세 ~ 21세 · 모든 성별 · 2025. 6. 12. 업데이트됨 · NCT06216899ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.